Ayça Muftuler Løndalen, FDG PET/CT and dosimetry studies after targeted therapy with 177Lu-lilotomab satetraxetan for lymphoma, Utgår fra Institutt for klinisk medisin. Disputas 2.2.2023.
Bedømmelseskomité: Francesco Cicone, University of Catanzaro, Italy, Lena Specht, University of Copenhagen, Denmark og Trond Mogens Aaløkken, Faculty of Medicine, University of Oslo
Hovedveileder: Caroline Stokke
Biveiledere: Mona-Elisabeth Revheim, Arne Kolstad
Public Defence: Ayça Muftuler Løndalen - Institute of Clinical Medicine (uio.no)